Radiopharm Theranostics Limited
Radiopharm Theranostics Limited (RADX) Market Cap & Net Worth
Live market cap, enterprise value, and global rank — multi-year chart and annual table below.
radx · market cap & enterprise value · FMP · as of Jun 8, 2026
Core market cap & key metrics
As of Jun 8, 2026, Radiopharm Theranostics Limited (RADX) has a market cap — also referred to as its net worth or valuation — of $5,423,322, making it one of the top most valuable companies globally. Market Cap = $4.21 × shares outstanding.
Market cap history — by year
* 2026 = year-to-date · Year-end market cap · Source: FMP
Market cap by year
Compared to Peers
View Healthcare sectorAbout Market Cap, Net Worth & Valuation
Radiopharm Theranostics Limited (RADX) has a market cap — also referred to as its net worth or valuation — of $5,423,322 as of Jun 8, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.
Radiopharm Theranostics Limited reached its all-time high market cap of $219,549,708.896 on Dec 6, 2024. Comparing the Radiopharm Theranostics Limited market cap history illustrates one of the most extraordinary corporate growth stories.
Investors frequently compare Radiopharm Theranostics Limited net worth vs peers and ask how Radiopharm Theranostics Limited valuation compares to other countries. Its market cap reflects continued investor confidence.
Frequently Asked Questions
RADX market cap · 6 questionsRadiopharm Theranostics Limited's net worth — measured as market capitalization — is $5,423,322 as of Jun 8, 2026. It ranks #0 globally. Market Cap = $$4.21 (price) × shares outstanding.